Inato
PrivateLast Round
Series A
Extension
Mar 29, 2023
Total Funding Raised
$35.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inato operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A Extension round in March 2023.
Inato is a health technology company that provides an AI-powered platform to connect pharmaceutical sponsors, research sites, and patients to improve the accessibility, inclusivity, and efficiency of clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inato Comparables
Compare Inato with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elligo Health Research | 77% | |
| Reify Health | 75% | |
| Paradigm Health | 74% |
For institutional investors. Book with your work email.
Inato Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 29, 2023 | ||||
| Series A | Feb 4, 2020 | ||||
| Seed | Nov 15, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inato Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Seed |
| Top Harvest Capital | Series A Extension |
| Top Harvest Capital | Series A Extension |
| Serena Data Ventures | Series A |
| Obvious Ventures | Series A Extension, Series A |
| Fly Ventures | Series A, Seed |
| La Maison Partners | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Recognized on Fierce Healthcare’s Fierce 15 list.
- Apr 1, 2026
Platform now used by over 5,500 sites globally.
For institutional investors. Book with your work email.
Inato Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inato's valuation, stock price, and market status.
Is Inato a public or private company?
Inato is a private company.
What is the current stock price of Inato?
Inato is a private company, so its shares have no public market price. Caplight tracks Inato's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inato worth (valuation)?
Valuation information for Inato is not publicly available.
Can I buy Inato stock?
Inato shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inato's last funding round?
Inato's most recent funding round was Series A Extension on March 29, 2023.
Who are the main investors in Inato?
Key investors in Inato include Obvious Ventures, Cathay Innovation.
Will Inato IPO soon?
No public IPO plans have been announced for Inato.
How can I track Inato secondary market activity?
Caplight tracks bids, offers, and trades in Inato's shares on secondary markets.